サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629296

標的シーケンシング・リシーケンシングの世界市場：技術別・種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Targeted Sequencing and Resequencing Market, By Technology, By Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 355 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
標的シーケンシング・リシーケンシングの世界市場：技術別・種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 355 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

標的シーケンシング・リシーケンシングの市場規模は2024年に61億2,467万米ドルとなり、2025年から2032年にかけてCAGR 22.6％で拡大

標的シーケンシング・リシーケンシングの市場力学

個別化医療への需要の高まりが標的シーケンシング・リシーケンシング市場の成長を牽引

個別化医療に対する需要の高まりが、標的シーケンシング・リシーケンシング市場の拡大に拍車をかけています。ゲノム技術の開発により、正確な患者層別化と薬剤開発が可能になりました。米国国立衛生研究所（NIH）は、個別化治療をサポートするためにゲノム研究に多額の投資を行っており、2020年だけで2億米ドル以上が研究に割り当てられています。このような研究の急増は、より正確な診断・治療ツールの開発に役立っています。さらに、標的シーケンシングは腫瘍学において極めて重要な役割を果たしており、臨床試験では標的療法によって生存率が向上することが示されています。さらに、個人の遺伝子プロファイルに基づいて治療を調整する医療機関の進行中の取り組みが、標的シーケンシングの採用を促進しており、がんや希少遺伝性疾患におけるより良い治療成績の達成に役立っています。

標的シーケンシング・リシーケンシング市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約22.6%のCAGRで毎年成長すると予測されています。

技術別に見ると、シーケンシング技術は2024年に最大市場シェアを示すと予測されました。

種類別では、DNAベースの標的シーケンシングが2024年の主要タイプでした。

用途別では、臨床用途が2024年の主要用途でした。

地域別では、北米が2024年の主要収益源でした。

標的シーケンシング・リシーケンシング市場：セグメンテーション分析

世界の標的シーケンシング・リシーケンシング市場は、技術、種類、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は技術に基づいて2つのカテゴリーに分けられます：シーケンシングとリシーケンシングです。シーケンシングは、臨床診断および研究における幅広い用途により、最も高い市場シェアを占めています。リシーケンシングは、遺伝子変異に関する重要な洞察を提供し、個別化医療や疾病管理に役立ちます。

市場は種類によって2つのカテゴリーに分けられます：DNAベースの標的シーケンシングとRNAベースの標的シーケンシングです。DNAベースの標的シークエンシングは、遺伝子解析および疾患検出におけるその広範な使用によりリードしています。RNAベース標的シーケンシングは、特にがん研究や医薬品開発において、遺伝子発現や制御に関する重要な洞察を提供します。

標的シーケンシング・リシーケンシング市場：地域別分析

標的シーケンシング・リシーケンシング市場は、ゲノミクスと個別化医療の進歩に牽引され、さまざまな地域で力強い成長を遂げています。北米が最大の市場シェアを占めていますが、これは主に大手バイオテクノロジー企業の存在、米国国立衛生研究所（NIH）などの機関からの強力な研究資金、がん治療における標的療法の採用拡大によるものです。米国は重要なプレーヤーであり、精密医療への多額の投資がこの地域の優位性に貢献しています。欧州も重要な役割を果たしており、ドイツ、英国、フランスなどの国々がゲノム研究と精密医療への注力を強めています。アジア太平洋地域は、医療費の増加、政府の取り組み、高度な診断ツールに対する需要の高まりにより、高成長地域として浮上しています。中国とインドは特に遺伝子研究能力を拡大しており、市場成長を助長する環境を醸成しています。ラテンアメリカと中東市場は、意識の高まりと医療投資の増加により、大きな可能性を示すと予想されます。

標的シーケンシング・リシーケンシング市場：競合情勢

標的シーケンシング・リシーケンシング市場は競争が激しく、複数の主要企業が技術的進歩や製品提供で主導権を握っています。イルミナ、サーモフィッシャーサイエンティフィック、ロシュなどの企業が最先端で、最先端のシーケンシングプラットフォーム、試薬、サービスを提供しています。イルミナは次世代シーケンサー（NGS）技術で市場を独占しており、臨床診断、研究、医薬品開発に広く利用されています。サーモフィッシャーサイエンティフィックも重要な役割を果たしており、標的シーケンシングに不可欠なシーケンシングソリューションとバイオインフォマティクスツールを提供しています。ロシュは、Foundation Medicineのような精密腫瘍学に特化した企業の買収を通じて、包括的なゲノム・ソリューションを提供しています。Pacific Biosciences社やQiagen社などの新興企業は、ロングリードシーケンシング技術や新しいキットでサービスを強化しています。これらに加えて、複数のバイオテクノロジー企業や学術機関が、希少遺伝子疾患、個別化医療、標的創薬などのニッチな用途に注力しており、市場競争を激化させています。戦略的提携、合併、買収は、急速に進化するこの分野で市場での地位を強化し、製品ポートフォリオを拡大するための一般的な戦略です。

目次

第1章 標的シーケンシング・リシーケンシング市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 標的シーケンシング・リシーケンシングの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 標的シーケンシング・リシーケンシング市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 標的シーケンシング・リシーケンシング市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 標的シーケンシング・リシーケンシングの市場情勢

  • 標的シーケンシング・リシーケンシングの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 標的シーケンシング・リシーケンシング市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • シーケンシング
    • リシーケンシング
      • 電気泳動に基づく再配列
      • 次世代シーケンシング（NGS）
      • アレイベースの再配列

第8章 標的シーケンシング・リシーケンシング市場：種類別

  • 概要
    • セグメント別シェア分析：種類別
    • DNAベース標的シーケンシング
    • RNAベース標的シーケンシング

第9章 標的シーケンシング・リシーケンシング市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 臨床応用
      • 腫瘍学
      • 遺伝子検査・スクリーニング
      • 感染症
    • 植物・動物科学
    • 医薬品開発
    • その他

第10章 標的シーケンシング・リシーケンシング市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 研究機関・学術センター
    • 製薬・バイオテクノロジー企業
    • 病院・診療所
    • CRO (医薬品開発業務受託機関)
    • その他

第11章 標的シーケンシング・リシーケンシング市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：標的シーケンシング・リシーケンシング業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • 10x Genomics, Inc.
    • Agilent Technologies, Inc.
    • BGI Genomics Co., Ltd.
    • Eurofins Scientific
    • Illumina, Inc.
    • Macrogen, Inc.
    • MGI Tech Co., Ltd.
    • Myriad Genetics, Inc.
    • Novogene Corporation
    • Oxford Nanopore Technologies Ltd.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer, Inc.
    • PierianDx
    • QIAGEN NV
    • Roche Sequencing Solutions, Inc.
    • Thermo Fisher Scientific, Inc.
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4593

REPORT HIGHLIGHT

Targeted Sequencing and Resequencing Market size was valued at US$ 6,124.67 Million in 2024, expanding at a CAGR of 22.6% from 2025 to 2032.

The targeted sequencing and resequencing market focuses on high-throughput sequencing technologies that enable the precise analysis of specific genes or regions of the genome, offering improved resolution compared to whole-genome sequencing. Increased adoption of next-generation sequencing (NGS) techniques in oncology, precision medicine, and genetic research has contributed to market growth. For instance, nearly 40% of researchers in the genomics field reported using targeted sequencing methods for genetic studies in 2023. Factors such as growing demand for personalized medicine, technological advancements in sequencing tools, and increased healthcare investments further propel market growth. However, high costs associated with sequencing equipment and data storage, along with a lack of skilled professionals, may hinder broader adoption. On the other hand, market opportunities exist in developing regions where genetic testing demand is rapidly increasing, along with advancements in cloud-based platforms for better data storage and management. Partnerships between academic institutions and biotech companies are also fostering innovation in targeted sequencing technology.

Targeted Sequencing and Resequencing Market- Market Dynamics

Rising Demand for Personalized Medicine Drives Growth in the Targeted Sequencing and Resequencing Market

The growing demand for personalized medicine is fueling the expansion of the targeted sequencing and resequencing market. Advancements in genomic technologies have enabled precise patient stratification and drug development. The U.S. National Institutes of Health (NIH) has invested significantly in genomics to support personalized therapies, with over $200 million allocated to research in 2020 alone. This surge in research is helping in the development of more accurate diagnostic and therapeutic tools. Additionally, targeted sequencing plays a pivotal role in oncology, with clinical trials showcasing that targeted therapies can enhance survival rates. Moreover, the ongoing initiatives by healthcare institutions to tailor treatments based on individual genetic profiles are driving the adoption of targeted sequencing, helping to achieve better outcomes in cancer and rare genetic disorders.

Targeted Sequencing and Resequencing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.6% over the forecast period (2025-2032)

Based on Technology segmentation, Sequencing Technology was predicted to show maximum market share in the year 2024

Based on Type segmentation, DNA-based Targeted Sequencing was the leading Type in 2024

Based on Application segmentation, Clinical Applications was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Targeted Sequencing and Resequencing Market- Segmentation Analysis:

The Global Targeted Sequencing and Resequencing Market is segmented on the basis of Technology, Type, Application, End-User, and Region.

The market is divided into two categories based on Technology: Sequencing and Re-sequencing. Sequencing holds the highest market share due to its broad application in clinical diagnostics and research. Re-sequencing follows closely, offering crucial insights into genetic variations and aiding in personalized medicine and disease management.

The market is divided into two categories based on Type: DNA-based Targeted Sequencing and RNA-based Targeted Sequencing. DNA-based targeted sequencing leads due to its widespread use in genetic analysis and disease detection. RNA-based targeted sequencing follows, offering critical insights into gene expression and regulation, particularly in cancer research and drug development.

Targeted Sequencing and Resequencing Market- Geographical Insights

The targeted sequencing and resequencing market is witnessing strong growth across various regions, driven by advancements in genomics and personalized medicine. North America holds the largest market share, primarily due to the presence of major biotech firms, strong research funding from institutions like the National Institutes of Health (NIH), and the growing adoption of targeted therapies in cancer treatment. The U.S. is a key player, with significant investments in precision medicine, contributing to the region's dominance. Europe also plays a crucial role, with countries like Germany, the UK, and France increasing their focus on genomic research and precision healthcare. The Asia-Pacific region is emerging as a high-growth area, driven by rising healthcare expenditure, government initiatives, and the growing demand for advanced diagnostic tools. China and India are particularly expanding their genetic research capabilities, fostering an environment conducive to market growth. The Latin American and Middle Eastern markets are expected to show significant potential due to increasing awareness and rising healthcare investments.

Targeted Sequencing and Resequencing Market- Competitive Landscape:

The targeted sequencing and resequencing market is highly competitive, with several key players leading the charge in technological advancements and product offerings. Companies like Illumina, Thermo Fisher Scientific, and Roche are at the forefront, offering cutting-edge sequencing platforms, reagents, and services. Illumina dominates the market with its next-generation sequencing (NGS) technology, which is widely used in clinical diagnostics, research, and drug development. Thermo Fisher Scientific also plays a significant role, providing sequencing solutions and bioinformatics tools that are crucial for targeted sequencing. Roche offers comprehensive genomic solutions through its acquisition of companies like Foundation Medicine, focusing on precision oncology. Emerging players such as Pacific Biosciences and Qiagen are enhancing their offerings with long-read sequencing technologies and new kits. In addition to these, several biotechnology firms and academic institutions are focusing on niche applications like rare genetic disorders, personalized medicine, and targeted drug discovery, intensifying market competition. Strategic collaborations, mergers, and acquisitions are common strategies to strengthen market positions and expand product portfolios in this rapidly evolving space.

Recent Developments:

In March 2024, The WHO launched new guidance on targeted next-generation sequencing (NGS) tests for diagnosing drug-resistant tuberculosis, enhancing rapid detection of drug resistance. Additionally, a TB sequencing portal was introduced, featuring over 56,000 sequences to support research and diagnostics.

In May 2024, Baylor Genetics introduced its RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS). Additionally, the company reduced the turnaround time for WES and WGS to three weeks, offering reports within five days.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific
  • Illumina, Inc.
  • Macrogen, Inc.
  • MGI Tech Co., Ltd.
  • Myriad Genetics, Inc.
  • Novogene Corporation
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • PierianDx
  • QIAGEN N.V.
  • Roche Sequencing Solutions, Inc.
  • Thermo Fisher Scientific, Inc.
  • Others

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Sequencing
  • Re-sequencing
  • Electrophoresis-based Resequencing
  • Next-Generation Sequencing (NGS)
  • Array-based Resequencing

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • DNA-based Targeted Sequencing
  • RNA-based Targeted Sequencing

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical Applications
  • Oncology
  • Genetic Screening and Testing
  • Infectious Diseases
  • Plant & Animal Sciences
  • Drug Development
  • Others

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Research Institutes and Academic Centers
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Contract Research Organizations (CROs)
  • Others

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Targeted Sequencing and Resequencing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Targeted Sequencing and Resequencing Market Snippet by Technology
    • 2.1.2. Targeted Sequencing and Resequencing Market Snippet by Type
    • 2.1.3. Targeted Sequencing and Resequencing Market Snippet by Application
    • 2.1.4. Targeted Sequencing and Resequencing Market Snippet by End-User
    • 2.1.5. Targeted Sequencing and Resequencing Market Snippet by Country
    • 2.1.6. Targeted Sequencing and Resequencing Market Snippet by Region
  • 2.2. Competitive Insights

3. Targeted Sequencing And Resequencing Key Market Trends

  • 3.1. Targeted Sequencing and Resequencing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Targeted Sequencing and Resequencing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Targeted Sequencing and Resequencing Market Opportunities
  • 3.4. Targeted Sequencing and Resequencing Market Future Trends

4. Targeted Sequencing And Resequencing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Targeted Sequencing And Resequencing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Targeted Sequencing and Resequencing Market Landscape

  • 6.1. Targeted Sequencing and Resequencing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Targeted Sequencing and Resequencing Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Sequencing
    • 7.1.3. Re-sequencing
      • 7.1.3.1. Electrophoresis-based Resequencing
      • 7.1.3.2. Next-Generation Sequencing (NGS)
      • 7.1.3.3. Array-based Resequencing

8. Targeted Sequencing and Resequencing Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. DNA-based Targeted Sequencing
    • 8.1.3. RNA-based Targeted Sequencing

9. Targeted Sequencing and Resequencing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Clinical Applications
      • 9.1.2.1. Oncology
      • 9.1.2.2. Genetic Screening and Testing
      • 9.1.2.3. Infectious Diseases
    • 9.1.3. Plant & Animal Sciences
    • 9.1.4. Drug Development
    • 9.1.5. Others

10. Targeted Sequencing and Resequencing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Research Institutes and Academic Centers
    • 10.1.3. Pharmaceutical and Biotechnology Companies
    • 10.1.4. Hospitals and Clinics
    • 10.1.5. Contract Research Organizations (CROs)
    • 10.1.6. Others

11. Targeted Sequencing And Resequencing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Targeted Sequencing And Resequencing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Targeted Sequencing And Resequencing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Targeted Sequencing And Resequencing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Targeted Sequencing And Resequencing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Targeted Sequencing And Resequencing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Targeted Sequencing And Resequencing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. 10x Genomics, Inc.
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. BGI Genomics Co., Ltd.
    • 12.2.4. Eurofins Scientific
    • 12.2.5. Illumina, Inc.
    • 12.2.6. Macrogen, Inc.
    • 12.2.7. MGI Tech Co., Ltd.
    • 12.2.8. Myriad Genetics, Inc.
    • 12.2.9. Novogene Corporation
    • 12.2.10. Oxford Nanopore Technologies Ltd.
    • 12.2.11. Pacific Biosciences of California, Inc.
    • 12.2.12. PerkinElmer, Inc.
    • 12.2.13. PierianDx
    • 12.2.14. QIAGEN N.V.
    • 12.2.15. Roche Sequencing Solutions, Inc.
    • 12.2.16. Thermo Fisher Scientific, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us